TMCI
Treace Medical Concepts Inc
Price:  
6.21 
USD
Volume:  
202,997.00
United States | Health Care Equipment & Supplies
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

TMCI EV/EBITDA

-368.7%
Upside

As of 2025-07-11, the EV/EBITDA ratio of Treace Medical Concepts Inc (TMCI) is -10.03. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. TMCI's latest enterprise value is 430.66 mil USD. TMCI's TTM EBITDA according to its financial statements is -42.95 mil USD. Dividing these 2 quantities gives us the above TMCI EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 18.1x - 25.1x 21.7x
Forward P/E multiples 23.8x - 28.3x 25.3x
Fair Price (16.92) - (17.79) (16.68)
Upside -372.4% - -386.5% -368.7%
6.21 USD
Stock Price
(16.68) USD
Fair Price

TMCI EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-07-10 -10.03
2025-07-09 -10.04
2025-07-08 -9.95
2025-07-07 -9.79
2025-07-03 -9.98
2025-07-02 -9.85
2025-07-01 -9.75
2025-06-30 -9.54
2025-06-27 -9.35
2025-06-26 -9.12
2025-06-25 -9.68
2025-06-24 -9.60
2025-06-23 -9.34
2025-06-20 -9.00
2025-06-18 -8.93
2025-06-17 -8.90
2025-06-16 -9.37
2025-06-13 -9.24
2025-06-12 -9.53
2025-06-11 -9.97
2025-06-10 -9.97
2025-06-09 -9.57
2025-06-06 -9.44
2025-06-05 -9.38
2025-06-04 -9.38
2025-06-03 -9.44
2025-06-02 -9.34
2025-05-30 -9.34
2025-05-29 -9.51
2025-05-28 -9.50
2025-05-27 -9.85
2025-05-23 -9.54
2025-05-22 -9.87
2025-05-21 -10.14
2025-05-20 -10.73
2025-05-19 -10.79
2025-05-16 -10.77
2025-05-15 -10.82
2025-05-14 -10.77
2025-05-13 -11.15
2025-05-12 -11.47
2025-05-09 -10.92
2025-05-08 -11.97
2025-05-07 -11.48
2025-05-06 -11.74
2025-05-05 -11.65
2025-05-02 -11.56
2025-05-01 -11.68
2025-04-30 -11.30
2025-04-29 -11.26